	الربح الإجمالي على المبيعات		تاريخ
Acadia Pharmaceuticals	USD 256.99M	13.15M	2025-09
Agios Pharmaceuticals	USD 11.2M	448K	2025-09
Akebia Therapeutics	USD 49.21M	13.25M	2025-03
Alnylam Pharmaceuticals	USD 1.05B	418.14M	2025-09
Anika Therapeutics	USD 14.68M	9.46M	2025-03
Arrowhead Research	USD 256.47M	228.7M	2025-09
AstraZeneca	USD 12.39B	5M	2025-12
Bristol-Myers Squibb	USD 8.79B	110M	2025-09
Eli Lilly	USD 14.59B	1.48B	2025-09
Enanta Pharmaceuticals	-22.29M	23.75M	2024-12
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
Halozyme Therapeutics	USD 281.77M	2.41M	2025-09
Heron Therapeutics	USD 23.35M	1.6M	2024-09
Insmed	USD 111.44M	33.36M	2025-09
J&J	USD 16.6B	118M	2025-12
Lexicon Pharmaceuticals	USD -16.16M	2.89M	2024-06
Ligand Pharmaceuticals	USD 155.28M	82.42M	2025-09
Merck	USD 13.42B	431M	2025-09
Minerva Neurosciences	-4.27M	26.79M	2024-12
Moderna	USD 809M	791M	2025-09
Novartis	USD 10.82B	694M	2025-09
Pfizer	USD 3.54B	7.61B	2025-09
PTC Therapeutics	USD 187.69M	24.3M	2025-09
Puma Biotechnology	USD 20.32M	24.85M	2024-09
Sangamo BioSciences	-2.39M	1.09M	2024-06
Sanofi	EUR 8.45B	1.31B	2025-12
Takeda	JPY 790.55B	262.97B	2025-12
Teva Pharmaceutical Industries	USD 2.66B	351M	2025-12
Ultragenyx Pharmaceutical	USD 131.94M	11.55M	2025-09
Vanda Pharmaceuticals	USD 50.6M	5.5M	2024-12
Veracyte	USD 91.28M	1.51M	2025-09

Vanda Pharmaceuticals الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.